ArticleOncoTargets and therapy2019

Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223.

Giandomenico Roviello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.